TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market:  The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio.  TeraRecon is an Advanced Visualization (AV) and Artificial Intelligence (AI) software developer with three main solutions: iNtuition, its AV platform; EnvoyAI, its AI marketplace for radiology; and NorthStar AI Explorer, the platform interface between its marketplace and the end-user.  The SymphonyAI Group is a portfolio of companies developing new generation AI solutions across multiple industries. Its founder, Romesh Wadhwani, has committed over $1 billion to build the Group’s portfolio.